The aim of an effective treatment in GBS is to rapidly stop the autoimmune damage on nerve cells, allowing patients to regain muscle strength sooner and to regain independence and return to pre ...

Kochi: The first GBS death was on Tuesday reported in Kerala after a 58-year-old died of Guillain-Barre Syndrome in Kochi. The patient was undergoing treatment in Kottayam Medical College.

GBS is a neuromuscular emergency and rare autoimmune disease that affects at least 150,000 people worldwide each year, with no FDA-approved therapies.

Further analysis of efficacy data will be conducted in 2024. 15-HMedIdeS-09 is an open-label, single arm, trial evaluating the safety, tolerability and efficacy of imlifidase in GBS patients in ...